These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8512107)

  • 21. The differential effect of halothane and 1,2-dichlorohexafluorocyclobutane on in vitro muscle contractures of patients susceptible to malignant hyperthermia.
    Kindler CH; Girard T; Gong D; Urwyler A
    Anesth Analg; 2002 Apr; 94(4):1028-33, table of contents. PubMed ID: 11916818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxacurium and mivacurium do not trigger malignant hyperthermia in susceptible swine.
    Sufit RL; Kreul JF; Bellay YM; Helmer P; Brunson DB; Will J
    Anesth Analg; 1990 Sep; 71(3):285-7. PubMed ID: 2144100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular and metabolic responses to anesthetic-induced malignant hyperthermia in swine.
    Roewer N; Dziadzka A; Greim CA; Kraas E; Schulte am Esch J
    Anesthesiology; 1995 Jul; 83(1):141-59. PubMed ID: 7604993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans.
    Weiskopf RB; Moore MA; Eger EI; Noorani M; McKay L; Chortkoff B; Hart PS; Damask M
    Anesthesiology; 1994 May; 80(5):1035-45. PubMed ID: 8017643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the systemic and coronary hemodynamic actions of desflurane, isoflurane, halothane, and enflurane in the chronically instrumented dog.
    Pagel PS; Kampine JP; Schmeling WT; Warltier DC
    Anesthesiology; 1991 Mar; 74(3):539-51. PubMed ID: 2001033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Malignant hyperthermia in swine: a study of atracurium in MH-susceptible swine].
    Williams C; Dozier S; Ilias W; Fulfer R
    Anaesthesiol Reanim; 1994; 19(1):23-5. PubMed ID: 8141961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenon does not trigger malignant hyperthermia in susceptible swine.
    Froeba G; Marx T; Pazhur J; Baur C; Baeder S; Calzia E; Eichinger HM; Radermacher P; Georgieff M
    Anesthesiology; 1999 Oct; 91(4):1047-52. PubMed ID: 10519508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of inositol polyphosphates in skeletal muscle during porcine malignant hyperthermia.
    Tonner PH; Scholz J; Richter A; Löscher W; Steinfath M; Wappler F; Wlaz P; Hadji B; Roewer N; Schulte am Esch J
    Br J Anaesth; 1995 Oct; 75(4):467-71. PubMed ID: 7488490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed onset of malignant hyperthermia in desflurane anesthesia.
    Hoenemann CW; Halene-Holtgraeve TB; Booke M; Hinder F; Daudel F; Reich A; Van Aken H
    Anesth Analg; 2003 Jan; 96(1):165-7, table of contents. PubMed ID: 12505945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior hypothermia attenuates malignant hyperthermia in susceptible swine.
    Iaizzo PA; Kehler CH; Carr RJ; Sessler DI; Belani KG
    Anesth Analg; 1996 Apr; 82(4):803-9. PubMed ID: 8615501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
    Allen GC; Rosenberg H; Fletcher JE
    Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The screening of propofol in MHS swine.
    Raff M; Harrison GG
    Anesth Analg; 1989 Jun; 68(6):750-1. PubMed ID: 2786680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of propofol on the malignant hyperthermia susceptible pig model.
    Krivosic-Horber R; Reyfort H; Becq MC; Adnet P
    Br J Anaesth; 1989 Jun; 62(6):691-3. PubMed ID: 2787665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eltanolone (5-beta-pregnanolone) does not trigger, and attenuates halothane triggering of, malignant hyperthermia in malignant hyperthermia susceptible swine.
    Harrison GG; Dyer RA; Llewellyn RL; James MF
    Pharmacol Res; 1999 Feb; 39(2):103-6. PubMed ID: 10072700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of volatile anesthetics on calcium regulation by malignant hyperthermia-susceptible sarcoplasmic reticulum.
    Louis CF; Zualkernan K; Roghair T; Mickelson JR
    Anesthesiology; 1992 Jul; 77(1):114-25. PubMed ID: 1609985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperthermia: pharmacology of triggering.
    Hopkins PM
    Br J Anaesth; 2011 Jul; 107(1):48-56. PubMed ID: 21624965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human malignant hyperthermia associated with desflurane anesthesia.
    Allen GC; Brubaker CL
    Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529
    [No Abstract]   [Full Text] [Related]  

  • 39. Cerebral uptake and elimination of desflurane, isoflurane, and halothane from rabbit brain: an in vivo NMR study.
    Lockhart SH; Cohen Y; Yasuda N; Freire B; Taheri S; Litt L; Eger EI
    Anesthesiology; 1991 Mar; 74(3):575-80. PubMed ID: 2001037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of volatile anesthetics on atrial and AV nodal electrophysiological properties in guinea pig isolated perfused heart.
    Raatikainen MJ; Trankina MF; Morey TE; Dennis DM
    Anesthesiology; 1998 Aug; 89(2):434-42. PubMed ID: 9710402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.